Articoli di letteratura

  1. Girolami F, Spinelli V, Maurizi N, Focardi M, Nesi G, Maio V, Grifoni R, Albora G, Bertaccini B, Targetti M, Coppini R, Favilli S, Olivotto I, Cerbai E. Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry.Front Cardiovasc Med. 2022 Dec 14;9:1080608. doi: 10.3389. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795053/
  2. Galanti G et al. Demographic and clinical determinants of judgment of unfitness for competitive sports in the Region of Tuscany: observational study of the period 2008-2014. MED SPORT 2016;69:194-203. http://www.minervamedica.it/en/journals/medicina-dello-sport/article.php?cod=R26Y2016N02A0194. 
  3. Zorzi A et al. Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive Athletes. Circ Arrhythm Electrophysiol. 2016 Jul. http://circep.ahajournals.org/content/9/7/e004229.long.
  4. Bagnall RD et al. A prospective study of sudden cardiac death among children and young adults. N Engl J Med. 2016 Jun 23. http://www.nejm.org/doi/full/10.1056/NEJMoa1510687. 
  5. Finocchiaro G et al. Etiology of Sudden Death in Sports Insights From a United Kingdom Regional Registry.  J Am Coll Cardiol.  2016 May 10. http://www.sciencedirect.com/science/article/pii/S0735109716015771.
  6. Solberg EE et al. Sudden cardiac arrest in sports – need for uniform registration: A Position Paper from the Sport Cardiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Prev Cardiol. 2016 Apr. http://cpr.sagepub.com/content/23/6/657.long.
  7. d’Amati G et al. Sudden cardiac death in an Italian competitive athlete: Pre-participation screening and cardiovascular emergency care are both essential. Int J Cardiol. 2016 Mar 1. http://www.sciencedirect.com/science/article/pii/S0167527316300122.
  8. Descatha A et al. Cardiac arrest in the workplace and its outcome: a systematic review and meta analysis. Resuscitation. 2015Nov. http://www.sciencedirect.com/science/article/pii/S0300957215003147.
  9. Olivotto I et al. Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations. Cardiovasc Res. 2015 Apr 1. http://cardiovascres.oxfordjournals.org/content/105/4/409.long.
  10. Girolami F et al. Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study. Circ Cardiovasc Genet. 2014 Dec. http://circgenetics.ahajournals.org/content/7/6/741.long.
  11. Lazzerini PE et al. Long QT syndrome an emerging role for inflammation and immunity. Front Cardiovasc Med. 2015 May 27. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712633/.
  12. Greg Mellor et al. Sudden Unexplained Death – Treating the Family. Arrhythm Electrophysiol Rev. 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711540/pdf/aer-03-156.pdf
  13. Basso C et al. Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking.
    Eur Heart J. 2004 Mar. http://eurheartj.oxfordjournals.org/content/25/6/531.long.